Questions to ask a gallbladder malpractice lawyer.

If you or a loved one is evaluating counsel for a bile duct injury or cholecystectomy-error case, the hardest part of the consultation is not asking the questions — it is listening past the confidence of the delivery to the content of the answer. Every plaintiff medical-malpractice firm will tell you it handles these cases. Many have handled one or two. A smaller number have handled fifty or more. The difference shows up in trial outcomes, settlement leverage, and the depth of operative-report analysis that defense counsel know to expect.

The questions below are not conversational. They are designed to surface specifics — numbers, names, documents, timelines. A firm that has actually done this work answers specifically and comfortably. A firm that has generalized its marketing to cover any medical-malpractice case tends to pivot to broader credentials, unrelated verdicts, or the language of experience without the substance of it. Both patterns are informative.

Keep in mind that the initial consultation is free and confidential. You are not obligated to retain the firm on the call. The consultation is your due diligence, and the questions are a reasonable part of it. An experienced malpractice firm will welcome the specificity — because it demonstrates that you are engaging seriously, and because specific questions are the ones that distinguish the firm from the generalist competition.

The parent guide on choosing a gallbladder malpractice lawyer covers the broader framework — specialization, expert networks, fee structure, co-counsel. This page is the practical tool: the ten questions to bring to the call.

The first question is the most diagnostic. "How many bile duct injury or cholecystectomy-error cases has your firm handled in the past five years?" A firm with subspecialty focus answers specifically — a number, a range, a description of the Strasberg classes of the injuries, a discussion of typical case outcomes. A firm without specialty depth generalizes. "Several." "Many over the years." "We handle malpractice cases of all kinds."

The reason the answer matters is that expert relationships, operative-report literacy, and defense-counsel familiarity are all byproducts of volume. A firm that handles two bile duct cases a year cannot build the same expert network, the same library of comparable verdicts, or the same settlement leverage as a firm that handles thirty. Volume is not everything — a firm could handle volume poorly — but in this specialty, volume is a necessary condition.

What's more, the answer itself reveals something about how the firm thinks about the case. A lawyer who can describe the typical Strasberg classes the firm has litigated (Class E1 through E5 major bile duct injuries versus Class A cystic duct leaks versus Class B and C partial ligations) is speaking the vocabulary of the case. A lawyer who cannot is signaling that the firm's experience with these cases is thin.

Note that "medical malpractice cases generally" is not an answer. Anesthesia cases, birth injury cases, and delayed cancer diagnoses are all medical malpractice — and they all require different experts, different vocabularies, and different trial strategies. The specific question is about cholecystectomy-related cases, and the specific answer is the one that matters.

"Have you taken a gallbladder malpractice case to verdict, and what was the outcome?" This is the question that insurance defense counsel already knows the answer to about the firm you are evaluating — and it drives settlement leverage in cases that never go to trial.

Most medical-malpractice cases settle. That is the right outcome in most cases, and a good firm negotiates hard and settles well. But the firms that can try cases settle cases on better terms. Defense firms and their insurance carriers track which plaintiff firms will actually take a case to a jury versus which will settle for less rather than face trial preparation. A firm with a known willingness and ability to try cases carries leverage that a purely negotiation-oriented firm does not.

A firm that has tried medical-malpractice cases can discuss specific verdicts — not promises about your case, but a record. When was the firm last in trial? What was the outcome? Can the firm point to a verdict in a case comparable to yours? Ethical firms can discuss their trial record without breaching client confidentiality, because trial records are public. Appellate decisions are especially probative: a firm that has defended plaintiffs' verdicts on appeal, or overturned adverse trial rulings, has demonstrated procedural and substantive depth that distinguishes it from firms that only do pre-trial work.

Be aware that "we try cases when necessary" is not an answer. The follow-up is "when was the last time, and what was the outcome?" If the firm cannot point to a recent malpractice trial, the settlement leverage in your case will be proportional to that absence.

"Who are the hepatobiliary surgery experts you work with?" The answer should be specific — names, credentials, case history. "We have a network of experts we retain" is not an answer. The names of retained experts are not confidential unless the firm and expert have a specific agreement about non-disclosure, and in that case the firm can still describe the credentials.

The experts who matter in a bile duct injury case are specific. First, a board-certified general or hepatobiliary surgeon who can credibly opine on whether the critical view of safety was achieved and whether the standard of care was met during the cholecystectomy. Second, a radiologist who can review pre-operative imaging, intraoperative cholangiograms if performed, and post-operative studies — the HIDA scan, the MRCP, the ERCP. Third, a hepatobiliary specialist who can speak to the reconstruction options and long-term outcomes for Roux-en-Y hepaticojejunostomy and similar repairs. Fourth, a vocational expert and economist to build the earning-capacity and life-care-plan components of damages. Fifth, a certified life-care planner.

Each of these is a specific person with specific credentials who has testified in specific cases. Firms that handle bile duct cases routinely have established relationships across all five categories. Firms that do not have to scramble to assemble a team for each case, often at higher cost and lower expert quality. The cost of retaining experts — often $100,000 to $200,000 in a major bile duct case — is one of the main reasons these cases are expensive. The firm advances those costs on contingency, meaning the firm is taking real financial risk on the case. Firms that cannot underwrite that risk without strain cannot build cases to the depth the defense will require.

Coverage of the specific reconstruction in your case matters too. For context on the clinical territory, see our resource on common bile duct injury — the section on Strasberg E-class injuries and Roux-en-Y repair is the terrain the experts will be litigating.

"What fee percentage do you charge, and are case costs advanced by the firm or passed through to me along the way?" The answer should be specific, disclosed in writing, and easy for the firm to walk through in detail.

Medical-malpractice representation is contingency work in nearly every U.S. jurisdiction. The firm advances every cost; you pay nothing up front; the firm is repaid from any recovery. The contingency percentage is typically 33⅓% to 40%, with some states applying sliding scales at higher recovery thresholds and some states (including Florida, under rules of the Florida Bar) applying specific caps in medical-malpractice matters. The ABA Model Rules of Professional Conduct — Rule 1.5 — require fees to be reasonable and require contingency agreements to be in writing, signed by the client, and to specify how expenses are handled. The mechanics — what the percentage covers, what expenses are advanced, what state caps apply — are treated in full on how contingency fees work in medical malpractice.

What the engagement letter says about case costs is where the practical differences between firms appear. Most firms advance all costs and deduct them from the recovery before the fee percentage is calculated. Some firms structure this differently, with costs coming out after the fee or shared between fee and recovery in a specific formula. The practical effect on the client's net recovery can be substantial in cases where costs run high. Ask specifically: "If my case settles for X, after expert fees of Y and your Z% contingency fee, what do I actually take home?" An experienced firm can walk through the math concretely.

What happens if you lose at trial? Under the contingency structure, you owe no legal fees — but in most jurisdictions, a losing plaintiff can be responsible for certain defense costs (not attorney fees, typically, but court costs and sometimes specific statutory fees depending on the state). Many firms absorb these as a matter of practice. Others do not. Ask the question directly, and confirm the answer in the engagement letter.

Finally, ask how liens are handled. Health-insurance subrogation, Medicare and Medicaid set-asides, hospital liens — all of these can significantly reduce the net recovery, and experienced firms know how to negotiate liens down substantially. A firm without medical-malpractice-specific lien-negotiation experience may leave meaningful recovery on the table after the case settles.

"How is the Strasberg classification relevant to my case?" and "Can you explain the critical view of safety and why it matters?" These are not gotcha questions. They are vocabulary tests, and they reveal whether the lawyer can read an operative report with the precision the case requires.

The Strasberg classification is the universal language for bile duct injuries during cholecystectomy. Class A is a bile leak from a minor duct (the cystic duct stump or a duct of Luschka). Class B and C are partial or complete occlusions of an aberrant right hepatic duct. Class D is a lateral injury to a major bile duct. Classes E1 through E5 are complete transections at progressively higher levels of the biliary tree — the higher the level, the more complex the repair and the worse the long-term prognosis. A lawyer who handles these cases routinely can discuss the classes, describe which ones are most commonly litigated, and explain the clinical and legal significance of each.

The critical view of safety is the surgical standard for identifying the cystic duct and cystic artery before they are divided. The surgeon is supposed to skeletonize the triangle of Calot, expose both structures in continuity with the gallbladder, and confirm that only two structures are entering the gallbladder before dividing anything. When the critical view is not achieved and the surgeon proceeds anyway, the likelihood of misidentifying the common bile duct as the cystic duct — and clipping or dividing it — goes up substantially. The critical view is the center of gravity in most bile duct injury cases, because it is the standard the expert will opine on.

A lawyer who cannot discuss these concepts at the level of a senior resident is not going to cross-examine a defense surgical expert on their own terms. The vocabulary is not optional; it is the terrain the case will be fought on.

"If my case needs to be filed in another state, how does your firm handle co-counsel arrangements?" For a specialty firm with a national practice, this question is routine. The answer should describe the structure — the specialty firm leads substantive work, licensed local counsel handles the filing and local procedure, fees are shared under the fee-sharing rule in the relevant state (typically ABA Model Rule 1.5(e) or the state's equivalent) with written disclosure to the client. The client signs one engagement; the engagement identifies both firms and describes the arrangement. The full tradeoff analysis between a national specialty firm versus a local generalist sits one level deeper in this decision.

"What is a realistic timeline from engagement to resolution?" Realistic answers vary by jurisdiction and case complexity, but the range is usually two to four years for cases that proceed through discovery and either settle or try. Cases that settle earlier (strong liability, limited damages dispute, cooperative insurer) can resolve in twelve to eighteen months. Cases that try typically run three or more years. Watch for promises of fast resolution; they are usually marketing rather than forecasting.

"What does the initial review process look like?" A structured answer describes a process: intake and initial screening, records collection over thirty to ninety days, expert review, case decision. An unstructured answer ("we take a look and let you know") is a tell. Experienced firms have a documented intake protocol because the first ninety days of records review drive the case.

Note that the initial review is typically free and does not obligate either party. If the firm declines to take the case, the records and work product belong to you; you can take them to another firm. If the firm takes the case, the engagement letter governs from that point forward.

Some answers are themselves warning signs. Be aware of the patterns below when evaluating firms.

• Dollar promises at intake. No ethical firm can guarantee a specific recovery at the first call, and doing so is inconsistent with ABA Model Rule 7.1 (which prohibits false or misleading communications about a lawyer's services). Case value depends on records review, expert opinion, and negotiation — none of which have happened at intake. Any firm that promises a number is either inexperienced or deliberately misrepresenting.
• "We take any case that comes in." Subspecialty depth requires selectivity. A firm that does not screen cases carefully cannot build the expert relationships or trial record that give leverage in settlement.
• Refusal to name experts. The experts the firm retains are not confidential in the normal case, and the firm can describe credentials and case history even when specific names are under protective order. Firms that cannot describe their expert network are signaling that the network is thinner than the marketing implies.
• No specific verdict history. "We try cases when necessary" is not a verdict history. The follow-up is "when was the last trial, and what was the outcome?"
• Too-fast promises. A consultation that pushes you to sign a fee agreement on the first call, without time to review the engagement letter, is a pressure tactic. Ethical firms allow time for review.
• Generic answers to specific questions. When you ask about cholecystectomy-error cases and the answer is about "medical malpractice experience" broadly, the specific experience is thin.
• Heavy marketing, thin specialty depth. Television advertising, billboards, and search saturation are expensive but not informative about specialty depth. Some firms with heavy marketing also have real specialty expertise; some do not. The questions on this page are how to tell the difference. State bar rules on attorney advertising (varying by state) and directory standards from Avvo, Super Lawyers, and Best Lawyers are descriptive indicators — not endorsements, and not substitutes for the consultation questions.

The right firm will answer every question on this page specifically, will not rush the engagement decision, will explain the fee and cost structure in detail, and will treat you as a partner in the case. The consultation is free; the time to ask the questions is now.